Related Experiment Video
Updated: Oct 15, 2025

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
Published on: December 29, 2023
Synthesis and analysis of small molecules to restrain the function of tissue factor within tumour cells
Oluremi I Adeniran1, Mohammad A Mohammad2, Sophie Featherby2
1Department of Chemistry, University of Hull, HU6 7RX Hull, UK.
Abstract:
Introduction: The restriction of prolyl-protein cis/trans isomerase 1 (Pin1) activity has been shown to prevent the release of tissue factor (TF) leading to the accumulation of the latter protein within the cell. This study tested the ability of novel small molecules to inhibit Pin1, suppress TF activity and release, and induce cellular apoptosis. Methods: Four compounds were designed and synthesised based on modification of 5-(p-methoxyphenyl)-2-methylfuran-3-carbonyl amide and the outcome on MDA-MB-231 and primary cells examined. These compounds contained 3-(2-naphthyl)-D-alanine (4a), D-tryptophan (4b), D-phenylalanine (4c), and D-tyrosine (4d) at the amino-termini. Results: Treatment of cells with compound 4b and 4d reduced the cell-surface TF activity after 60 min on MDA-MB-231 cells. Incubation with compound 4d also reduced TF antigen on the cell surface and its incorporation into microvesicles, while compounds 4a and 4b significantly increased TF release. None of the four compounds significantly altered the total amount of TF antigen or TF mRNA expression. Compound 4b and 4d also suppressed the binding of Pin1 to TF-cytoplasmic domain peptide. However, compound 4d reduced while compound 4b increased the Pin1 isomerase activity. Finally, treatment with compound 4b and 4d reduced the cell numbers, increased nuclear localisation of p53, Bax protein and bax mRNA expression and induced cellular apoptosis in MDA-MB-231 but not primary endothelial cells. Conclusions: In conclusion, we have identified small molecules to regulate the function of TF within cells. Two of these compounds may prove to be beneficial in moderating TF function specifically and restrain TF-mediated tumour growth without detrimental outcomes on normal vascular cells.
Insights
Novel small molecules targeting prolyl-protein cis/trans isomerase 1 (Pin1) were developed. Two compounds effectively regulated tissue factor (TF) activity and induced apoptosis in cancer cells, suggesting potential for targeted cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Prolyl-protein cis/trans isomerase 1 (Pin1) activity is linked to tissue factor (TF) release.
- TF accumulation within cells can have significant biological consequences.
- Targeting Pin1 offers a potential strategy to modulate TF function.
Purpose of the Study:
- To design and synthesize novel small molecules inhibiting Pin1.
- To evaluate the effects of these compounds on TF activity, release, and cellular apoptosis.
- To assess the specificity of these compounds on cancer versus primary cells.
Main Methods:
- Synthesis of four novel amide compounds with varying amino-termini (D-alanine, D-tryptophan, D-phenylalanine, D-tyrosine).
- Treatment of MDA-MB-231 (cancer) and primary cells with synthesized compounds.
- Assays to measure cell-surface TF activity, TF antigen, TF incorporation into microvesicles, Pin1 binding to TF peptide, Pin1 isomerase activity, and apoptosis markers (p53, Bax).
Main Results:
- Compounds 4b (D-tryptophan) and 4d (D-tyrosine) reduced cell-surface TF activity and Pin1 binding to TF peptide.
- Compound 4d decreased TF antigen and microvesicle incorporation; compounds 4a and 4b increased TF release.
- Compounds 4b and 4d induced apoptosis in MDA-MB-231 cells by increasing p53 and Bax, without affecting primary endothelial cells.
Conclusions:
- Novel small molecules were identified that modulate TF function.
- Compounds 4b and 4d show promise in regulating TF activity and inducing cancer cell apoptosis.
- These compounds may offer a therapeutic strategy for TF-mediated tumor growth with minimal impact on normal vascular cells.
More Related Videos
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Clot Retraction and Fibrinolysis
The Tumor Microenvironment
Anticoagulant Drugs: Low-Molecular-Weight Heparins